StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Earnings

Bicycle Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 16, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$34.10M
+190.6% on a year earlier
EPS, Q3 FY2026
-$0.15
-$0.85 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Bicycle Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Oct 29, 2026before the open$34.10M+190.6%-$0.15Release
Q2 FY2026ended Jun 30, 2026Jul 30, 2026before the open$629.00K-78.5%-$0.72Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026before the open$900.00K-91.0%-$0.87Release
Q4 FY2025ended Dec 31, 2025Mar 17, 2026before the open$48.00M+1194.5%-$0.29Release
Q3 FY2025ended Sep 30, 2025Oct 30, 2025before the open$11.73M+338.5%-$0.85Release
Q2 FY2025ended Jun 30, 2025Aug 8, 2025before the open$2.92M-68.8%-$1.14Release
Q1 FY2025ended Mar 31, 2025May 1, 2025before the open$9.98M-48.9%-$0.88Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$3.71M-30.4%-$0.75Release
Q3 FY2024ended Sep 30, 2024Oct 31, 2024before the open$2.68M-50.0%-$0.74Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$9.36M-17.9%-$0.77Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$19.53M+298.9%-$0.62Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Bicycle Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Bicycle Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Bicycle Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. Results
  5. News
  6. Results
  7. News
  8. Results
  9. Results
  10. Results
  11. Update
  12. News
  13. Results
  14. Update
  15. News

See a number that looks wrong?